title: Practical use of povidone-iodine antiseptic in the maintenance of oral health and in the prevention and treatment of common oropharyngeal infections.
abstract: OBJECTIVE
  To better inform medical practitioners on the role of antiseptics in oropharyngeal health and disease, this article focuses on povidone-iodine (PVP-I), an established and widely-available antiseptic agent.
  
  
  METHODS
  Review of the anti-infective profile, efficacy and safety of PVP-I in managing common upper respiratory tract infections such as the common cold, influenza and tonsillo-pharyngitis, as well as oral complications resulting from cancer treatment (oral mucositis), and dental conditions (periodontitis, caries).
  
  
  RESULTS
  Antiseptics with broad-spectrum anti-infective activity and low resistance potential offer an attractive option in both infection control and prevention. While there is some evidence of benefit of antiseptics in a variety of clinical settings that include dental and oral hygiene, dermatology, oncology, and pulmonology, there appears to be discordance between the evidence-base and practice. This is especially apparent in the management and prevention of oropharyngeal infections, for which the use of antiseptics varies considerably between clinical practices, and is in marked contrast to their dermal application, where they are extensively used as both a prophylaxis and a treatment of skin and wound infections, thus minimising the use of antibiotics.
  
  
  CONCLUSIONS
  The link between oral and oropharyngeal health status and susceptibility to infection has long been recognised. The high rates of antibiotic misuse and subsequent development of bacterial resistance (e.g. increasing vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA)) in large parts of the world, especially across Asia Pacific, highlight the need for identifying alternative antimicrobials that would minimise the use of these medications. This, together with recent large-scale outbreaks of, for example, avian and swine influenza virus, further underline the importance of an increasing armamentarium for infection prevention and control.
authors.affiliation: Lee Kong Chian School of Medicine, NTU-Imperial College, Singapore.
authors.forename: J
authors.initials: J
authors.lastname: Kanagalingam
authors.affiliation: Department of Otolaryngology, St Luke's Medical Center, Global City, Philippines.
authors.forename: R
authors.initials: R
authors.lastname: Feliciano
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
authors.forename: J H
authors.initials: JH
authors.lastname: Hah
authors.affiliation: Dr. Hussein Labib Dental Clinic, Dubai, United Arab Emirates.
authors.forename: H
authors.initials: H
authors.lastname: Labib
authors.affiliation: Department of Oncology, Cho Ray hospital, Ho Chi Minh City, Vietnam.
authors.forename: T A
authors.initials: TA
authors.lastname: Le
authors.affiliation: Department of Radiation Oncology, Taichung Veterans General Hospital, Taichung, Taiwan.
authors.forename: J-C
authors.initials: JC
authors.lastname: Lin
mesh_terms: D000891:Anti-Infective Agents, Local / Q000494:pharmacology / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D006801:Humans; D017053:Infection Control / Q000379:methods; D009059:Mouth Diseases / Q000188:drug therapy* / Q000517:prevention & control; D009181:Mycoses / Q000188:drug therapy; D011206:Povidone-Iodine / Q000494:pharmacology / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000517:prevention & control; D014777:Virus Diseases / Q000188:drug therapy
chemical_list: D000891:Anti-Infective Agents, Local; D011206:Povidone-Iodine